(Q42989759)

12 November 2017

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action (English)

1 reference

12 November 2017

11

1 reference

12 November 2017

4

Gerken G

1 reference

12 November 2017

Bréchot C

1

1 reference

12 November 2017

Jaffredo F

2

1 reference

12 November 2017

Lagorce D

3

1 reference

12 November 2017

Meyer zum Büschenfelde K

5

1 reference

12 November 2017

Papakonstontinou A

6

1 reference

12 November 2017

Hadziyannis S

7

1 reference

12 November 2017

Romeo R

8

1 reference

12 November 2017

Colombo M

9

1 reference

12 November 2017

Rodes J

10

1 reference

12 November 2017

Williams R

12

1 reference

12 November 2017

Naoumov N

13

1 reference

12 November 2017

1 August 1998

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

29

1 reference

12 November 2017

173-183

1 reference

12 November 2017

2

1 reference

Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatocellular carcinoma: Recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus as a causative agent of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis B and C viral infections in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis B virus infection without immunological markers after open-heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Isolation of novel virus-like sequences associated with human hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus antibody and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Sequence analysis of hepatitis B virus DNA in immunologically negative infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Identification and transmission of hepatitis B virus-related variants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Transmission of hepatitis B from hepatitis-B-seronegative subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

"Occult" hepatitis B virus as source of infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on noncirrhotic livers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Effects of ethanol on hepatitis B virus Pre-S/S gene expression in the human hepatocellular carcinoma derived HEP G2 hepatitis B DNA positive cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Clearance of HBsAg in seven patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis B virus persistence after recovery from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis B virus HBx gene and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

HCV-associated liver cancer without cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

HCV-associated hepatocellular carcinoma without cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980001-9

7 January 2021

10.1016/S0168-8278(98)80001-9

Identifiers

DOI

1 reference

12 November 2017

1 reference